Filing Details

Accession Number:
0001104659-25-012362
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-12 19:57:25
Reporting Period:
2025-02-10
Filing Date:
2025-02-12
Accepted Time:
2025-02-12 19:57:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773427 Springworks Therapeutics Inc. SWTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578771 Julie Hambleton C/O Springworks Therapeutics, Inc.
100 Washington Blvd.
Stamford CT 06902
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-10 13,774 $32.27 17,869 No 4 M Direct
Common Stock Disposition 2025-02-10 13,774 $53.01 4,095 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2025-02-10 13,774 $0.00 13,774 $32.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2033-05-24 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 1, 2024.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.02 to $40.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The shares underlying this option are fully vested.